Qiagen NV $ 51.92 0.75 (1.47%)
On watch
Volume:
1,050,854
Avg Vol (1m):
1,530,617
Market Cap $:
11.87 Bil
Enterprise Value $:
12.83 Bil
P/E (TTM):
1,730.67
P/B:
4.53
Financial Strength | 5/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.44 | ||
| Equity-to-Asset | 0.5 | ||
| Debt-to-Equity | 0.65 | ||
| Debt-to-EBITDA | 6.19 | ||
| Interest Coverage | 5.8 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 3.5 | ||
| Beneish M-Score | -2.45 | ||
| WACC vs ROIC | |||
Profitability Rank | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 25.87 | ||
| Net Margin % | 0.86 | ||
| ROE % | 0.54 | ||
| ROA % | 0.26 | ||
| ROC (Joel Greenblatt) % | 10.86 | ||
| 3-Year Revenue Growth Rate | 6.3 | ||
| 3-Year EBITDA Growth Rate | -8.1 |
QGEN
Valuation Rank | 1/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 1730.67 | ||
| Forward PE Ratio | 22.47 | ||
| PE Ratio without NRI | 1730.67 | ||
| PB Ratio | 4.53 | ||
| PS Ratio | 7.42 | ||
| Price-to-Free-Cash-Flow | 99.85 | ||
| Price-to-Operating-Cash-Flow | 33.71 | ||
| EV-to-EBIT | 186.1 | ||
| EV-to-EBITDA | 46.53 | ||
| EV-to-Revenue | 7.96 | ||
| Shiller PE Ratio | 106.98 | ||
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.5 | ||
| Days Inventory | 119.38 | ||
| Days Sales Outstanding | 84.36 | ||
| Days Payable | 64.29 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 3.31 | ||
| Price-to-Median-PS-Value | 1.65 | ||
| Earnings Yield (Greenblatt) % | 0.54 | ||
| Forward Rate of Return (Yacktman) % | -0.55 |